Genetic determinants of telomere length and risk of pancreatic cancer a PANDoRA study /

Telomere deregulation is a hallmark of cancer. Telomere length measured in lymphocytes (LTL) has been shown to be a risk marker for several cancers. For pancreatic ductal adenocarcinoma (PDAC) consensus is lacking whether risk is associated with long or short telomeres. Mendelian randomization appro...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Campa Daniele
Matarazzi Martina
Greenhalf William
Bijlsma Maarten
Saum Kai-Uwe
Pasquali Claudio
van Laarhoven Hanneke
Szentesi Andrea Ildikó
Federici Francesca
Vodicka Pavel
Funel Niccola
Pezzilli Raffaele
Bueno-de-Mesquita H. Bas
Vodickov Ludmila
Hegyi Péter
Dokumentumtípus: Cikk
Megjelent: 2019
Sorozat:INTERNATIONAL JOURNAL OF CANCER 144 No. 6
doi:10.1002/ijc.31928

mtmt:30306949
Online Access:http://publicatio.bibl.u-szeged.hu/22005
LEADER 02976nab a2200373 i 4500
001 publ22005
005 20210803110411.0
008 210803s2019 hu o 0|| zxx d
022 |a 0020-7136 
024 7 |a 10.1002/ijc.31928  |2 doi 
024 7 |a 30306949  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Campa Daniele 
245 1 0 |a Genetic determinants of telomere length and risk of pancreatic cancer   |h [elektronikus dokumentum] :  |b a PANDoRA study /  |c  Campa Daniele 
260 |c 2019 
300 |a 1275-1283 
490 0 |a INTERNATIONAL JOURNAL OF CANCER  |v 144 No. 6 
520 3 |a Telomere deregulation is a hallmark of cancer. Telomere length measured in lymphocytes (LTL) has been shown to be a risk marker for several cancers. For pancreatic ductal adenocarcinoma (PDAC) consensus is lacking whether risk is associated with long or short telomeres. Mendelian randomization approaches have shown that a score built from SNPs associated with LTL could be used as a robust risk marker. We explored this approach in a large scale study within the PANcreatic Disease ReseArch (PANDoRA) consortium. We analyzed 10 SNPs (ZNF676-rs409627, TERT-rs2736100, CTC1-rs3027234, DHX35-rs6028466, PXK-rs6772228, NAF1-rs7675998, ZNF208-rs8105767, OBFC1-rs9420907, ACYP2-rs11125529 and TERC-rs10936599) alone and combined in a LTL genetic score ("teloscore", which explains 2.2% of the telomere variability) in relation to PDAC risk in 2,374 cases and 4,326 controls. We identified several associations with PDAC risk, among which the strongest were with the TERT-rs2736100 SNP (OR = 1.54; 95%CI 1.35-1.76; p = 1.54x10-10 ) and a novel one with the NAF1-rs7675998 SNP (OR = 0.80; 95%CI 0.73-0.88; p = 1.87x10-6 , ptrend = 3.27x10-7 ). The association of short LTL, measured by the teloscore, with PDAC risk reached genome-wide significance (p = 2.98x10-9 for highest vs. lowest quintile; p = 1.82x10-10 as a continuous variable). In conclusion, we present a novel genome-wide candidate SNP for PDAC risk (TERT-rs2736100), a completely new signal (NAF1-rs7675998) approaching genome-wide significance and we report a strong association between the teloscore and risk of pancreatic cancer, suggesting that telomeres are a potential risk factor for pancreatic cancer. This article is protected by copyright. All rights reserved. 
700 0 1 |a Matarazzi Martina  |e aut 
700 0 1 |a Greenhalf William  |e aut 
700 0 1 |a Bijlsma Maarten  |e aut 
700 0 1 |a Saum Kai-Uwe  |e aut 
700 0 1 |a Pasquali Claudio  |e aut 
700 0 2 |a van Laarhoven Hanneke  |e aut 
700 0 2 |a Szentesi Andrea Ildikó  |e aut 
700 0 2 |a Federici Francesca  |e aut 
700 0 2 |a Vodicka Pavel  |e aut 
700 0 2 |a Funel Niccola  |e aut 
700 0 2 |a Pezzilli Raffaele  |e aut 
700 0 2 |a Bueno-de-Mesquita H. Bas  |e aut 
700 0 2 |a Vodickov Ludmila  |e aut 
700 0 2 |a Hegyi Péter  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/22005/1/CampaIntJCancer2019.pdf  |z Dokumentum-elérés